EUDA Health Holdings Limited (NASDAQ: EUDA) Stock Competitors & Peer Comparison
See EUDA's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for EUDA and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| EUDA | $13.51 | -8.84% | 40.8M | -11.69 | -$1.16 | N/A |
| HCA | $494.99 | -2.46% | 103.4B | 17.09 | $28.96 | +0.62% |
| THC | $283.33 | -1.09% | 22.5B | 16.43 | $17.24 | N/A |
| EHC | $137.54 | -2.64% | 13.6B | 23.56 | $5.84 | +0.57% |
| FMS | $23.40 | -1.10% | 12.5B | 8.80 | $2.66 | +3.70% |
| DVA | $191.35 | -1.78% | 12B | 13.56 | $14.11 | N/A |
| ENSG | $181.08 | -0.72% | 10.6B | 26.23 | $6.90 | +0.14% |
| UHS | $195.50 | -1.56% | 10.1B | 8.67 | $22.54 | +0.41% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| PACS | $49.60 | -1.20% | 7.9B | 26.23 | $1.89 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
EUDA vs HCA Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, HCA has a market cap of 103.4B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while HCA trades at $494.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas HCA's P/E ratio is 17.09. In terms of profitability, EUDA's ROE is -5.06%, compared to HCA's ROE of -1.00%. Regarding short-term risk, EUDA is more volatile compared to HCA. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
EUDA vs THC Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, THC has a market cap of 22.5B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while THC trades at $283.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas THC's P/E ratio is 16.43. In terms of profitability, EUDA's ROE is -5.06%, compared to THC's ROE of +0.61%. Regarding short-term risk, EUDA is more volatile compared to THC. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check THC's competition here
Encompass Health Corporation (NYSE: EHC)
EUDA vs EHC Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, EHC has a market cap of 13.6B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while EHC trades at $137.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas EHC's P/E ratio is 23.56. In terms of profitability, EUDA's ROE is -5.06%, compared to EHC's ROE of +0.25%. Regarding short-term risk, EUDA is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check EHC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
EUDA vs FMS Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, FMS has a market cap of 12.5B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while FMS trades at $23.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas FMS's P/E ratio is 8.80. In terms of profitability, EUDA's ROE is -5.06%, compared to FMS's ROE of +0.06%. Regarding short-term risk, EUDA is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check FMS's competition here
DaVita Inc. (NYSE: DVA)
EUDA vs DVA Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, DVA has a market cap of 12B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while DVA trades at $191.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas DVA's P/E ratio is 13.56. In terms of profitability, EUDA's ROE is -5.06%, compared to DVA's ROE of -1.33%. Regarding short-term risk, EUDA is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check DVA's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
EUDA vs ENSG Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, ENSG has a market cap of 10.6B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while ENSG trades at $181.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas ENSG's P/E ratio is 26.23. In terms of profitability, EUDA's ROE is -5.06%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, EUDA is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check ENSG's competition here
Universal Health Services, Inc. (NYSE: UHS)
EUDA vs UHS Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, UHS has a market cap of 10.1B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while UHS trades at $195.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas UHS's P/E ratio is 8.67. In terms of profitability, EUDA's ROE is -5.06%, compared to UHS's ROE of +0.20%. Regarding short-term risk, EUDA is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check UHS's competition here
Oak Street Health, Inc. (NYSE: OSH)
EUDA vs OSH Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas OSH's P/E ratio is -17.65. In terms of profitability, EUDA's ROE is -5.06%, compared to OSH's ROE of +4.64%. Regarding short-term risk, EUDA is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
EUDA vs PACS Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, PACS has a market cap of 7.9B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while PACS trades at $49.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas PACS's P/E ratio is 26.23. In terms of profitability, EUDA's ROE is -5.06%, compared to PACS's ROE of +0.26%. Regarding short-term risk, EUDA is more volatile compared to PACS. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
EUDA vs CHE Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, CHE has a market cap of 6.9B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while CHE trades at $528.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas CHE's P/E ratio is 24.44. In terms of profitability, EUDA's ROE is -5.06%, compared to CHE's ROE of +0.32%. Regarding short-term risk, EUDA is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check CHE's competition here
Hims & Hers Health, Inc. (NYSE: HIMS)
EUDA vs HIMS Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, HIMS has a market cap of 5.8B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while HIMS trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas HIMS's P/E ratio is -40.62. In terms of profitability, EUDA's ROE is -5.06%, compared to HIMS's ROE of -0.30%. Regarding short-term risk, EUDA is more volatile compared to HIMS. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check HIMS's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
EUDA vs CON Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, CON has a market cap of 5.4B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while CON trades at $42.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas CON's P/E ratio is 26.54. In terms of profitability, EUDA's ROE is -5.06%, compared to CON's ROE of +0.48%. Regarding short-term risk, EUDA is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check CON's competition here
LHC Group, Inc. (NASDAQ: LHCG)
EUDA vs LHCG Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas LHCG's P/E ratio is 82.83. In terms of profitability, EUDA's ROE is -5.06%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, EUDA is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
EUDA vs LFST Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, LFST has a market cap of 5.3B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while LFST trades at $13.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas LFST's P/E ratio is 103.71. In terms of profitability, EUDA's ROE is -5.06%, compared to LFST's ROE of +0.05%. Regarding short-term risk, EUDA is more volatile compared to LFST. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check LFST's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
EUDA vs OPCH Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, OPCH has a market cap of 4.7B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while OPCH trades at $31.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas OPCH's P/E ratio is 18.40. In terms of profitability, EUDA's ROE is -5.06%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, EUDA is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check OPCH's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
EUDA vs ACHC Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, ACHC has a market cap of 3.4B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while ACHC trades at $37.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas ACHC's P/E ratio is 18.58. In terms of profitability, EUDA's ROE is -5.06%, compared to ACHC's ROE of -0.57%. Regarding short-term risk, EUDA is more volatile compared to ACHC. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check ACHC's competition here
Amedisys, Inc. (NASDAQ: AMED)
EUDA vs AMED Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas AMED's P/E ratio is 39.30. In terms of profitability, EUDA's ROE is -5.06%, compared to AMED's ROE of +0.04%. Regarding short-term risk, EUDA is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check AMED's competition here
National HealthCare Corporation (AMEX: NHC)
EUDA vs NHC Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, NHC has a market cap of 3.3B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while NHC trades at $208.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas NHC's P/E ratio is 26.46. In terms of profitability, EUDA's ROE is -5.06%, compared to NHC's ROE of +0.10%. Regarding short-term risk, EUDA is more volatile compared to NHC. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check NHC's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
EUDA vs SGRY Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, SGRY has a market cap of 3B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while SGRY trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas SGRY's P/E ratio is 59.45. In terms of profitability, EUDA's ROE is -5.06%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, EUDA is more volatile compared to SGRY. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check SGRY's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
EUDA vs AVAH Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, AVAH has a market cap of 2.9B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while AVAH trades at $13.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas AVAH's P/E ratio is 19.47. In terms of profitability, EUDA's ROE is -5.06%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, EUDA is more volatile compared to AVAH. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check AVAH's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
EUDA vs GRDN Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, GRDN has a market cap of 2.7B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while GRDN trades at $42.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas GRDN's P/E ratio is 37.14. In terms of profitability, EUDA's ROE is -5.06%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, EUDA is more volatile compared to GRDN. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check GRDN's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
EUDA vs MD Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, MD has a market cap of 2.4B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while MD trades at $31.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas MD's P/E ratio is 13.96. In terms of profitability, EUDA's ROE is -5.06%, compared to MD's ROE of +0.17%. Regarding short-term risk, EUDA is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check MD's competition here
Ardent Health Inc. (NYSE: ARDT)
EUDA vs ARDT Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, ARDT has a market cap of 2.4B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while ARDT trades at $17.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas ARDT's P/E ratio is 13.95. In terms of profitability, EUDA's ROE is -5.06%, compared to ARDT's ROE of +0.09%. Regarding short-term risk, EUDA is more volatile compared to ARDT. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check ARDT's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
EUDA vs ADUS Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, ADUS has a market cap of 2.3B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while ADUS trades at $124.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas ADUS's P/E ratio is 18.61. In terms of profitability, EUDA's ROE is -5.06%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, EUDA is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check ADUS's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
EUDA vs BKD Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, BKD has a market cap of 2.2B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while BKD trades at $9.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas BKD's P/E ratio is -15.64. In terms of profitability, EUDA's ROE is -5.06%, compared to BKD's ROE of +0.89%. Regarding short-term risk, EUDA is more volatile compared to BKD. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check BKD's competition here
Select Medical Holdings Corporation (NYSE: SEM)
EUDA vs SEM Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, SEM has a market cap of 2B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas SEM's P/E ratio is 15.43. In terms of profitability, EUDA's ROE is -5.06%, compared to SEM's ROE of +0.08%. Regarding short-term risk, EUDA is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check SEM's competition here
Agilon Health, Inc. (NYSE: AGL)
EUDA vs AGL Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, AGL has a market cap of 1.9B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while AGL trades at $113.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas AGL's P/E ratio is -7.33. In terms of profitability, EUDA's ROE is -5.06%, compared to AGL's ROE of -0.52%. Regarding short-term risk, EUDA is more volatile compared to AGL. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check AGL's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
EUDA vs AMEH Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas AMEH's P/E ratio is 39.25. In terms of profitability, EUDA's ROE is -5.06%, compared to AMEH's ROE of +0.06%. Regarding short-term risk, EUDA is more volatile compared to AMEH. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check AMEH's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
EUDA vs ASTH Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, ASTH has a market cap of 1.7B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while ASTH trades at $34.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas ASTH's P/E ratio is 41.61. In terms of profitability, EUDA's ROE is -5.06%, compared to ASTH's ROE of +0.07%. Regarding short-term risk, EUDA is more volatile compared to ASTH. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check ASTH's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
EUDA vs HCSG Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, HCSG has a market cap of 1.6B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while HCSG trades at $24.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas HCSG's P/E ratio is 16.30. In terms of profitability, EUDA's ROE is -5.06%, compared to HCSG's ROE of +0.20%. Regarding short-term risk, EUDA is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check HCSG's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
EUDA vs SNDA Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, SNDA has a market cap of 1.6B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while SNDA trades at $32.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas SNDA's P/E ratio is -5.29. In terms of profitability, EUDA's ROE is -5.06%, compared to SNDA's ROE of -0.19%. Regarding short-term risk, EUDA is more volatile compared to SNDA. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check SNDA's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
EUDA vs USPH Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, USPH has a market cap of 1.5B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while USPH trades at $99.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas USPH's P/E ratio is 39.17. In terms of profitability, EUDA's ROE is -5.06%, compared to USPH's ROE of -0.00%. Regarding short-term risk, EUDA is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check USPH's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
EUDA vs AMN Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, AMN has a market cap of 1.4B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while AMN trades at $36.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas AMN's P/E ratio is 11.98. In terms of profitability, EUDA's ROE is -5.06%, compared to AMN's ROE of +0.15%. Regarding short-term risk, EUDA is less volatile compared to AMN. This indicates lower risk in terms of short-term price fluctuations for EUDA.Check AMN's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
EUDA vs PNTG Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, PNTG has a market cap of 1.3B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while PNTG trades at $36.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas PNTG's P/E ratio is 27.55. In terms of profitability, EUDA's ROE is -5.06%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, EUDA is more volatile compared to PNTG. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check PNTG's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
EUDA vs NUTX Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, NUTX has a market cap of 1.2B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while NUTX trades at $180.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas NUTX's P/E ratio is 7.15. In terms of profitability, EUDA's ROE is -5.06%, compared to NUTX's ROE of +0.44%. Regarding short-term risk, EUDA is more volatile compared to NUTX. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check NUTX's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
EUDA vs BKDT Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas BKDT's P/E ratio is N/A. In terms of profitability, EUDA's ROE is -5.06%, compared to BKDT's ROE of +0.89%. Regarding short-term risk, EUDA is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check BKDT's competition here
Innovage Holding Corp. (NASDAQ: INNV)
EUDA vs INNV Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, INNV has a market cap of 1.2B. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while INNV trades at $8.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas INNV's P/E ratio is -448.00. In terms of profitability, EUDA's ROE is -5.06%, compared to INNV's ROE of +0.04%. Regarding short-term risk, EUDA is more volatile compared to INNV. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check INNV's competition here
Talkspace, Inc. (NASDAQ: TALK)
EUDA vs TALK Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, TALK has a market cap of 870.6M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas TALK's P/E ratio is 774.34. In terms of profitability, EUDA's ROE is -5.06%, compared to TALK's ROE of +0.00%. Regarding short-term risk, EUDA is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check TALK's competition here
Enhabit, Inc. (NYSE: EHAB)
EUDA vs EHAB Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas EHAB's P/E ratio is -197.14. In terms of profitability, EUDA's ROE is -5.06%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, EUDA is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check EHAB's competition here
GMR Solutions Inc. (NYSE: GMRS)
EUDA vs GMRS Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, GMRS has a market cap of 672.6M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while GMRS trades at $12.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas GMRS's P/E ratio is -6.13. In terms of profitability, EUDA's ROE is -5.06%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, EUDA is more volatile compared to GMRS. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check GMRS's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
EUDA vs TOI Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas TOI's P/E ratio is -14.25. In terms of profitability, EUDA's ROE is -5.06%, compared to TOI's ROE of +1.51%. Regarding short-term risk, EUDA is more volatile compared to TOI. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check TOI's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
EUDA vs SRTA Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, SRTA has a market cap of 491M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while SRTA trades at $5.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas SRTA's P/E ratio is -26.16. In terms of profitability, EUDA's ROE is -5.06%, compared to SRTA's ROE of -0.09%. Regarding short-term risk, EUDA is more volatile compared to SRTA. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check SRTA's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
EUDA vs MCTA Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas MCTA's P/E ratio is 419.36. In terms of profitability, EUDA's ROE is -5.06%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, EUDA is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check MCTA's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
EUDA vs STLN Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, STLN has a market cap of 360.9M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while STLN trades at $3.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas STLN's P/E ratio is -11.83. In terms of profitability, EUDA's ROE is -5.06%, compared to STLN's ROE of +1.51%. Regarding short-term risk, EUDA is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for EUDA.Check STLN's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
EUDA vs VMD Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, VMD has a market cap of 347.6M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while VMD trades at $9.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas VMD's P/E ratio is 25.35. In terms of profitability, EUDA's ROE is -5.06%, compared to VMD's ROE of +0.11%. Regarding short-term risk, EUDA is more volatile compared to VMD. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check VMD's competition here
Auna S.A. (NYSE: AUNA)
EUDA vs AUNA Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, AUNA has a market cap of 346M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while AUNA trades at $4.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas AUNA's P/E ratio is 4.21. In terms of profitability, EUDA's ROE is -5.06%, compared to AUNA's ROE of +0.01%. Regarding short-term risk, EUDA is more volatile compared to AUNA. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check AUNA's competition here
Community Health Systems, Inc. (NYSE: CYH)
EUDA vs CYH Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, CYH has a market cap of 311.7M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while CYH trades at $2.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas CYH's P/E ratio is 3.03. In terms of profitability, EUDA's ROE is -5.06%, compared to CYH's ROE of +0.36%. Regarding short-term risk, EUDA is more volatile compared to CYH. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check CYH's competition here
Capital Senior Living Corporation (NYSE: CSU)
EUDA vs CSU Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas CSU's P/E ratio is 0.67. In terms of profitability, EUDA's ROE is -5.06%, compared to CSU's ROE of -0.23%. Regarding short-term risk, EUDA is more volatile compared to CSU. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check CSU's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
EUDA vs FVE Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas FVE's P/E ratio is -5.64. In terms of profitability, EUDA's ROE is -5.06%, compared to FVE's ROE of -0.15%. Regarding short-term risk, EUDA is more volatile compared to FVE. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check FVE's competition here
The Joint Corp. (NASDAQ: JYNT)
EUDA vs JYNT Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, JYNT has a market cap of 96.7M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while JYNT trades at $6.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas JYNT's P/E ratio is 45.60. In terms of profitability, EUDA's ROE is -5.06%, compared to JYNT's ROE of +0.30%. Regarding short-term risk, EUDA is more volatile compared to JYNT. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check JYNT's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
EUDA vs KDLYW Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas KDLYW's P/E ratio is N/A. In terms of profitability, EUDA's ROE is -5.06%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, EUDA is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for EUDA.Check KDLYW's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
EUDA vs PARK Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, PARK has a market cap of 94.5M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while PARK trades at $19.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas PARK's P/E ratio is 26.86. In terms of profitability, EUDA's ROE is -5.06%, compared to PARK's ROE of -0.18%. Regarding short-term risk, EUDA is more volatile compared to PARK. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check PARK's competition here
biote Corp. (NASDAQ: BTMD)
EUDA vs BTMD Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, BTMD has a market cap of 46.8M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while BTMD trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas BTMD's P/E ratio is 9.64. In terms of profitability, EUDA's ROE is -5.06%, compared to BTMD's ROE of +0.03%. Regarding short-term risk, EUDA is more volatile compared to BTMD. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check BTMD's competition here
AlerisLife Inc. (NASDAQ: ALR)
EUDA vs ALR Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas ALR's P/E ratio is -1.11. In terms of profitability, EUDA's ROE is -5.06%, compared to ALR's ROE of -0.15%. Regarding short-term risk, EUDA is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check ALR's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
EUDA vs CCEL Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, CCEL has a market cap of 39.9M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while CCEL trades at $4.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas CCEL's P/E ratio is -21.50. In terms of profitability, EUDA's ROE is -5.06%, compared to CCEL's ROE of +0.16%. Regarding short-term risk, EUDA is more volatile compared to CCEL. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check CCEL's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
EUDA vs AIRS Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, AIRS has a market cap of 38.7M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while AIRS trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas AIRS's P/E ratio is -17.91. In terms of profitability, EUDA's ROE is -5.06%, compared to AIRS's ROE of -0.09%. Regarding short-term risk, EUDA is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for EUDA.Check AIRS's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
EUDA vs IMAC Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas IMAC's P/E ratio is -2.27. In terms of profitability, EUDA's ROE is -5.06%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, EUDA is more volatile compared to IMAC. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check IMAC's competition here
DocGo Inc. (NASDAQ: DCGO)
EUDA vs DCGO Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, DCGO has a market cap of 24.7M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while DCGO trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas DCGO's P/E ratio is -0.13. In terms of profitability, EUDA's ROE is -5.06%, compared to DCGO's ROE of -1.16%. Regarding short-term risk, EUDA is more volatile compared to DCGO. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check DCGO's competition here
Cano Health, Inc. (NYSE: CANO-WT)
EUDA vs CANO-WT Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, EUDA's ROE is -5.06%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, EUDA is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for EUDA.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
EUDA vs AIH Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas AIH's P/E ratio is -2.78. In terms of profitability, EUDA's ROE is -5.06%, compared to AIH's ROE of +1.16%. Regarding short-term risk, EUDA is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for EUDA.Check AIH's competition here
P3 Health Partners Inc. (NASDAQ: PIIIW)
EUDA vs PIIIW Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, PIIIW has a market cap of 13.9M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas PIIIW's P/E ratio is N/A. In terms of profitability, EUDA's ROE is -5.06%, compared to PIIIW's ROE of +1.61%. Regarding short-term risk, EUDA is less volatile compared to PIIIW. This indicates lower risk in terms of short-term price fluctuations for EUDA.Check PIIIW's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
EUDA vs PIII Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, PIII has a market cap of 13.1M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while PIII trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas PIII's P/E ratio is -0.12. In terms of profitability, EUDA's ROE is -5.06%, compared to PIII's ROE of +1.61%. Regarding short-term risk, EUDA is more volatile compared to PIII. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check PIII's competition here
Cano Health, Inc. (NYSE: CANO)
EUDA vs CANO Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas CANO's P/E ratio is -0.01. In terms of profitability, EUDA's ROE is -5.06%, compared to CANO's ROE of -1.49%. Regarding short-term risk, EUDA is more volatile compared to CANO. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
EUDA vs FPCG Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas FPCG's P/E ratio is 0.09. In terms of profitability, EUDA's ROE is -5.06%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, EUDA is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
EUDA vs FTRP Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas FTRP's P/E ratio is -1.22. In terms of profitability, EUDA's ROE is -5.06%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, EUDA is more volatile compared to FTRP. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check FTRP's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
EUDA vs BMGL Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, BMGL has a market cap of 8.4M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while BMGL trades at $5.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas BMGL's P/E ratio is -1.06. In terms of profitability, EUDA's ROE is -5.06%, compared to BMGL's ROE of -0.11%. Regarding short-term risk, EUDA is more volatile compared to BMGL. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check BMGL's competition here
American Shared Hospital Services (AMEX: AMS)
EUDA vs AMS Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, AMS has a market cap of 7.8M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while AMS trades at $1.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas AMS's P/E ratio is -4.63. In terms of profitability, EUDA's ROE is -5.06%, compared to AMS's ROE of -0.07%. Regarding short-term risk, EUDA is more volatile compared to AMS. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check AMS's competition here
ModivCare Inc. (NASDAQ: MODV)
EUDA vs MODV Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas MODV's P/E ratio is -0.06. In terms of profitability, EUDA's ROE is -5.06%, compared to MODV's ROE of +0.88%. Regarding short-term risk, EUDA is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
EUDA vs GBNH Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas GBNH's P/E ratio is -0.06. In terms of profitability, EUDA's ROE is -5.06%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, EUDA is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for EUDA.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE)
EUDA vs RHE Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas RHE's P/E ratio is -1.79. In terms of profitability, EUDA's ROE is -5.06%, compared to RHE's ROE of +1.09%. Regarding short-term risk, EUDA is more volatile compared to RHE. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check RHE's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
EUDA vs RHE-PA Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, EUDA's ROE is -5.06%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, EUDA is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for EUDA.Check RHE-PA's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
EUDA vs TOIIW Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, EUDA's ROE is -5.06%, compared to TOIIW's ROE of +1.51%. Regarding short-term risk, EUDA is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check TOIIW's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
EUDA vs AIDX Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, AIDX has a market cap of 2.5M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while AIDX trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas AIDX's P/E ratio is -0.27. In terms of profitability, EUDA's ROE is -5.06%, compared to AIDX's ROE of -3.87%. Regarding short-term risk, EUDA is more volatile compared to AIDX. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check AIDX's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
EUDA vs IMACW Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas IMACW's P/E ratio is N/A. In terms of profitability, EUDA's ROE is -5.06%, compared to IMACW's ROE of +0.46%. Regarding short-term risk, EUDA is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for EUDA.Check IMACW's competition here
Starling Oncology Inc. Wt (NASDAQ: STLNW)
EUDA vs STLNW Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, STLNW has a market cap of 1.2M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while STLNW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas STLNW's P/E ratio is -0.04. In terms of profitability, EUDA's ROE is -5.06%, compared to STLNW's ROE of +1.51%. Regarding short-term risk, EUDA is less volatile compared to STLNW. This indicates lower risk in terms of short-term price fluctuations for EUDA.Check STLNW's competition here
Endovia Health Sciences, Inc. (AMEX: EDVA)
EUDA vs EDVA Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, EDVA has a market cap of 1.2M. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while EDVA trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas EDVA's P/E ratio is -0.01. In terms of profitability, EUDA's ROE is -5.06%, compared to EDVA's ROE of N/A. Regarding short-term risk, EUDA is more volatile compared to EDVA. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check EDVA's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
EUDA vs EUDAW Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, EUDAW has a market cap of 616.3K. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas EUDAW's P/E ratio is -0.01. In terms of profitability, EUDA's ROE is -5.06%, compared to EUDAW's ROE of -5.06%. Regarding short-term risk, EUDA is more volatile compared to EUDAW. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check EUDAW's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
EUDA vs NIVF Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, NIVF has a market cap of 552.8K. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while NIVF trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas NIVF's P/E ratio is 0.22. In terms of profitability, EUDA's ROE is -5.06%, compared to NIVF's ROE of -292.08%. Regarding short-term risk, EUDA is more volatile compared to NIVF. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check NIVF's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
EUDA vs CCM Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, CCM has a market cap of 536.9K. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while CCM trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas CCM's P/E ratio is -1.25. In terms of profitability, EUDA's ROE is -5.06%, compared to CCM's ROE of +0.05%. Regarding short-term risk, EUDA is more volatile compared to CCM. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check CCM's competition here
Talkspace, Inc. (NASDAQ: TALKW)
EUDA vs TALKW Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas TALKW's P/E ratio is 0.00. In terms of profitability, EUDA's ROE is -5.06%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, EUDA is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for EUDA.Check TALKW's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
EUDA vs MNDR Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, MNDR has a market cap of 23.3K. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while MNDR trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas MNDR's P/E ratio is -0.06. In terms of profitability, EUDA's ROE is -5.06%, compared to MNDR's ROE of -0.31%. Regarding short-term risk, EUDA is more volatile compared to MNDR. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check MNDR's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
EUDA vs NIVFW Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, NIVFW has a market cap of 20.5K. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while NIVFW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas NIVFW's P/E ratio is N/A. In terms of profitability, EUDA's ROE is -5.06%, compared to NIVFW's ROE of -292.08%. Regarding short-term risk, EUDA is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check NIVFW's competition here
Tenon Medical, Inc. (NASDAQ: TNONW)
EUDA vs TNONW Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, TNONW has a market cap of 5.6K. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while TNONW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas TNONW's P/E ratio is N/A. In terms of profitability, EUDA's ROE is -5.06%, compared to TNONW's ROE of N/A. Regarding short-term risk, EUDA is less volatile compared to TNONW. This indicates lower risk in terms of short-term price fluctuations for EUDA.Check TNONW's competition here
Hanger, Inc. (NYSE: HNGR)
EUDA vs HNGR Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, HNGR has a market cap of 0. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas HNGR's P/E ratio is 19.71. In terms of profitability, EUDA's ROE is -5.06%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, EUDA is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check HNGR's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
EUDA vs SLHGP Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, EUDA's ROE is -5.06%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, EUDA is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check SLHGP's competition here
New Frontier Health Corporation (NYSE: NFH)
EUDA vs NFH Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, NFH has a market cap of 0. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas NFH's P/E ratio is -19.75. In terms of profitability, EUDA's ROE is -5.06%, compared to NFH's ROE of -0.06%. Regarding short-term risk, EUDA is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check NFH's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
EUDA vs SLHG Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, SLHG has a market cap of 0. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas SLHG's P/E ratio is -1.48. In terms of profitability, EUDA's ROE is -5.06%, compared to SLHG's ROE of N/A. Regarding short-term risk, EUDA is more volatile compared to SLHG. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check SLHG's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
EUDA vs ATIP-WT Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, EUDA's ROE is -5.06%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, EUDA is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for EUDA.Check ATIP-WT's competition here
Almost Family Inc. (NASDAQ: AFAM)
EUDA vs AFAM Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, AFAM has a market cap of 0. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas AFAM's P/E ratio is N/A. In terms of profitability, EUDA's ROE is -5.06%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, EUDA is more volatile compared to AFAM. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
EUDA vs TLMD Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, TLMD has a market cap of 0. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas TLMD's P/E ratio is -1.60. In terms of profitability, EUDA's ROE is -5.06%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, EUDA is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check TLMD's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
EUDA vs DVCR Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, DVCR has a market cap of 0. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas DVCR's P/E ratio is 28.34. In terms of profitability, EUDA's ROE is -5.06%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, EUDA is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check DVCR's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
EUDA vs TLMDW Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas TLMDW's P/E ratio is N/A. In terms of profitability, EUDA's ROE is -5.06%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, EUDA is more volatile compared to TLMDW. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check TLMDW's competition here
Kindred Healthcare, Inc. (NYSE: KND)
EUDA vs KND Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, KND has a market cap of 0. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas KND's P/E ratio is -1.14. In terms of profitability, EUDA's ROE is -5.06%, compared to KND's ROE of -0.53%. Regarding short-term risk, EUDA is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check KND's competition here
DocGo Inc. (NASDAQ: DCGOW)
EUDA vs DCGOW Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas DCGOW's P/E ratio is N/A. In terms of profitability, EUDA's ROE is -5.06%, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, EUDA is more volatile compared to DCGOW. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check DCGOW's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
EUDA vs TVTY Comparison November 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDA stands at 40.8M. In comparison, TVTY has a market cap of 0. Regarding current trading prices, EUDA is priced at $13.51 on the NASDAQ, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDA currently has a P/E ratio of -11.69, whereas TVTY's P/E ratio is 19.06. In terms of profitability, EUDA's ROE is -5.06%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, EUDA is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for EUDA.Check TVTY's competition here